Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Radix Glycyrrhizae Preparata is the processed form of the dried roots and rhizomes of Glycyrrhiza uralensis, G. glabra, or G. inflata, commonly known as Chinese licorice. In traditional Chinese medicine (TCM), it is called "Zhi Gan Cao" and is prepared by stir-baking with honey to enhance its tonifying and harmonizing properties[3][4][5][7]. The main bioactive constituents are triterpene saponins (notably glycyrrhizin) and flavonoids[6][8]. Pharmacological activities include anti-inflammatory, antioxidative, anti-allergic, neuroprotective, hepatoprotective effects; it also moderates spasms, alleviates pain, eliminates phlegm, relieves coughs, clears toxins and harmonizes other herbs in TCM formulas[1][4][5][6]. It has been used for conditions such as sore throat, skin infections, food/drug intoxication, peptic ulcers and various inflammatory disorders[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on radix glycyrrhizae preparata.